International Journal of Clinical Pediatrics, ISSN 1927-1255 print, 1927-1263 online, Open Access |
Article copyright, the authors; Journal compilation copyright, Int J Clin Pediatr and Elmer Press Inc |
Journal website http://www.theijcp.org |
Original Article
Volume 3, Number 3, September 2014, pages 79-85
Study of Nucleated Red Blood Cell Counts in Asphyxiated Newborns and the Fetal Outcome
Tables
NRBCs/100 WBCs | Cases | Control | ||
---|---|---|---|---|
Number | Percentage | Number | Percentage | |
0 - 10 | 37 | 52.86% | 66 | 94.29% |
11 - 30 | 20 | 28.58% | 4 | 5.71% |
31 - 50 | 9 | 12.84% | 0 | 0.00% |
51 - 70 | 2 | 2.86% | 0 | 0.00% |
> 71 | 2 | 2.86% | 0 | 0.00% |
Total | 70 | 100% | 70 | 100% |
Stage of HIE | Number | Percentage |
---|---|---|
No | 29 | 41.43% |
Stage I | 10 | 14.28% |
Stage II | 22 | 31.43% |
Stage III | 9 | 12.86% |
Clinical characteristics | Cases (n = 70) | Control (n = 70) | t | P |
---|---|---|---|---|
Number of babies | 70 | 70 | - | - |
Birth weight (g) | 2,569.11 ± 511.50 | 2,751.78 ± 349.62 | 2.467 | 0.01 |
Gestational age (weeks) | 38.21 ± 2.39 | 38.93 ± 1.46 | 2.12 | 0.03 |
APGAR at 1 min | 3.86 ± 0.95 | 7.5 ± 0.53 | 24.95 | < 0.0001 |
APGAR at 5 min | 6.31 ± 0.91 | 9.51 ± 0.50 | 25.75 | < 0.0001 |
Maternal age | 24.44 ± 3.62 | 24.94 ± 2.75 | 0.92 | 0.359 |
Laboratory characteristics | Cases (n = 70) | Control (n = 70) | t | P |
---|---|---|---|---|
Hemoglobin (mg/dL) | 16.38 ± 1.90 | 15.68 ± 1.45 | 2.43 | 0.01 |
TLC | 21,257.79 ± 7,788.9 | 14,343.78 ± 3,987.3 | 6.61 | < 0.001 |
Polymorphs | 62.67 ± 15.19 | 65.38 ± 12.77 | 1.14 | 0.254 |
Lymphocytes | 35.75 ± 13.47 | 32.96 ±13.11 | 1.24 | 0.217 |
Eosinophils | 0.98 ± 1.79 | 1.59 ± 2.40 | 1.67 | 0.096 |
Monocytes | 0.042 ± 0.27 | 0.00 | - | - |
Hemotocrit | 50.46 ± 6.43 | 49.34 ± 4.35 | 1.205 | 0.230 |
Platelets | 1.902 ± 0.64 | 1.90 ± 0.79 | 0.023 | 0.984 |
NRBCs/100 WBCs | 17.43 ± 19.86 | 2.97 ± 4.79 | 5.919 | < 0.0001 |
Parameter | Minimum | Maximum | Mean | SD | r | P |
---|---|---|---|---|---|---|
APGAR at 1 min | 0 | 5 | 3.814 | 1.054 | -0.4396 | 0.0001 |
NRBCs | 0 | 92 | 17.428 | 19.863 |
Parameter | Minimum | Maximum | Mean | SD | r | P |
---|---|---|---|---|---|---|
APGAR at 5 min | 4 | 7 | 6.314 | 0.909 | -0.4544 | < 0.0001 |
NRBCs | 0 | 92 | 17.428 | 19.863 |
NRBCs/100 WBCs | No HIE | Stage I | Stage II | Stage III |
---|---|---|---|---|
Minimum | 0.00 | 0.00 | 5.00 | 14.00 |
Maximum | 25.00 | 28.00 | 63.00 | 92.00 |
Mean | 4.48 | 11.10 | 25.95 | 45.55 |
SD | 6.180 | 9.036 | 17.622 | 25.880 |
Groups | Mean deviation | q | P |
---|---|---|---|
No HIE vs. stage I | -6.617 | 1.772 | > 0.05 |
No HIE vs. stage II | -21.472 | 7.459 | < 0.001 |
No HIE vs. stage III | -40.073 | 10.315 | < 0.001 |
Stage I vs. stage II | -14.855 | 3.825 | < 0.05 |
Stage I vs. stage III | -33.456 | 7.152 | < 0.001 |
Stage II vs. stage III | -18.601 | 4.617 | < 0.01 |
HIE Stage | NRBCs | |||
---|---|---|---|---|
Shivaprakash et al (2013) [15] | SJ Fern et al (2004) [20] | Boskabadi et al (2010) [7] | Present study | |
No HIE | 7.25 ± 5.32 | 0 | 9.75 | 4.48 ± 6.18 |
HIE I | 10.43 ± 3.68 | 5.61 | 11.94 | 11.10 ± 9.03 |
HIE II | 18.63 ± 3.22 | 8.25 | 21.08 | 25.95 ± 17.62 |
HIE III | 30.83 ± 4.49 | 12.42 | 29.18 | 45.55 ± 25.88 |
P | 0.001 | < 0.000 | < 0.001 | < 0.0001 |